Martinez v. United States Of America

District Court, S.D. New York·Decided September 16, 2021·No. 1:20-cv-07275·Unknown

Opinion

USDC SDNY DOCUMENT UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC #: DATE FILED:_ 9/16/21 RICHARD MARTINEZ, : Plaintiff, : -against- : 20-CV-7275 (VEC) : OPINION AND ORDER UNITED STATES OF AMERICA, ROBERT : BEAUDOUIN, M.D., MANDEEP SINGH, P.A., : YOON KANG, P.A., WARDEN MCC, THE GEO : GROUP, INC., THE BROOKLYN HOSPITAL : CENTER, PHILLIP MCPHEARSON, M.D., and: JOHN/JANE DOES Nos. 1-10, : Defendants. : nnn K VALERIE CAPRONI, United States District Judge: Between July 2018 and November 2019, Plaintiff was in federal custody — first at Queens Detention Facility (“QDF”), a private facility operated by Defendant The GEO Group, Inc. (“GEO Group”), and later at the Metropolitan Correctional Center (“MCC”), a U.S. Bureau of Prisons (“BOP”) facility — while awaiting trial on a criminal charge. Over the course of those 16 or so months, Plaintiff repeatedly complained about, inter alia, blood in his urine, painful urination, and back, leg, and chest pain. Although Plaintiff recetved some care from the medical staff at QDF and MCC, Plaintiff was not seen by a urologist or oncologist for months, despite MCC medical personnel issuing multiple referrals. Unfortunately, by the time Plaintiff did see appropriate specialists in November 2019, it was too late; Plaintiff was diagnosed with Stage IV prostate cancer and found to be paraplegic as a result of tumors having spread to his spine. According to Plaintiff, Defendants are liable for providing substandard medical care and

failing to diagnose and treat his serious medical ailments before they had progressed to such a devastating state. Plaintiff has sued those who were involved in his medical care while in pretrial detention. Plaintiff has sued three members of MCC’s medical staff, Dr. Robert Beaudouin, P.A. Mandeep Singh, and P.A. Yoon Kang (collectively the “Individual Federal Defendants,” and with the

United States, the “Federal Defendants”), pursuant to Bivens v. Six Unknown Named Agents of Fed. Bureau of Narcotics, 403 U.S. 388 (1971), for cruel and unusual punishment under the Eighth Amendment and for deprivation of his substantive due process rights under the Fifth Amendment.1 Plaintiff has also sued the United States under the Federal Tort Claims Act, 28 U.S.C. § 2671 et seq., for medical malpractice, negligence, and negligent hiring, supervision, and retention. Finally, Plaintiff brings a state law medical malpractice claim against the non-federal Defendants involved in Plaintiff’s care.2 Federal Defendants moved to dismiss Plaintiff’s Bivens and FTCA claims pursuant to Federal Rules of Civil Procedure 12(b)(1) and 12(b)(6). Notice of Mot., Dkt. 65. For the

following reasons, Federal Defendants’ motion to dismiss is GRANTED in part and DENIED in part.

1 Plaintiff has also sued the Warden of MCC and John/Jane Does Nos. 1–10, alleged to be personnel employed by BOP or MCC who worked in administrative or other capacities at MCC.

2 Plaintiff voluntarily dismissed the Kingsbrook Jewish Medical Center on August 6, 2021. See Dkt. 89. BACKGROUND3 On or around July 26, 2018, Plaintiff, who at the time was 49 years old, was arrested. Compl. ¶¶ 41–42, Dkt. 1. Between the date of his arrest and August or September 2018, Plaintiff was held as a pretrial detainee at QDF, a private facility managed by the GEO Group. Id. ¶¶ 41, 46. While incarcerated at QDF, Plaintiff complained to the medical staff about blood in his urine

(the medical term for which is hematuria) and painful, frequent urination; a urine sample revealed red or orange colored urine with a foul odor. Id. ¶ 43. QDF medical staff suspected that Plaintiff had a urinary tract infection (“UTI”); although no urine culture was performed, they placed Plaintiff on antibiotics. Id. ¶¶ 44–45. In late August or early September 2018, BOP transferred Plaintiff to MCC. Id. ¶¶ 46–47. Shortly after arriving at MCC, on September 11, 2018, Plaintiff had a urine sample collected for analysis; the urinalysis yielded abnormal results. Id. ¶ 47. The results of the urinalysis were co- signed by Dr. Beaudouin on May 3, 2019, with no treatment or additional testing occurring during the intervening eight months. Id. On May 31, 2019, Plaintiff was evaluated by Dr.

Beaudouin for hematuria, which Plaintiff reported having started nine months prior but having worsened in the prior two weeks. Id. ¶ 48. Dr. Beaudouin determined that Plaintiff may have a UTI, and he prescribed Plaintiff antibiotics. Id. Dr. Beaudouin also requested a computerized tomography (“CT”) scan of Plaintiff’s abdomen and pelvis and issued a referral for a urology evaluation, both of which were scheduled to occur within a month. Id. ¶¶ 48–49. Nearly two months later, on July 24, 2019, Plaintiff was taken to Kingsbrook Jewish Medical Center for a CT scan, the results of which indicated that Plaintiff had multiple enlarged

3 The facts are based on the allegations contained in Plaintiff’s complaint, unless otherwise stated. For purposes of Defendants’ motion, the Court accepts all well-pled, non-conclusory factual allegations in the complaint as true and draws all reasonable inferences in the light most favorable to Plaintiff. Tandon v. Captain’s Cove Marina of Bridgeport, Inc., 752 F.3d 239, 243 (2d Cir. 2014); Gibbons v. Malone, 703 F.3d 595, 599 (2d Cir. 2013). lymph nodes and an enlarged prostate; combined with Plaintiff’s history of hematuria, the Kingsbrook medical staff warned of malignancy and recommended that Plaintiff undergo a prostate-specific antigen (“PSA”) test. Id. ¶ 51. Plaintiff’s PSA test indicated a significantly elevated PSA level, and, on August 4, 2019, at which point Plaintiff still had not seen a urologist, Dr. Beaudouin created an administrative note stating that he would rewrite the urology referral

and would request a prostate biopsy to further evaluate Plaintiff for prostate cancer. Id. ¶¶ 52– 53. On August 28, 2019, following a second PSA test that confirmed Plaintiff’s significantly elevated PSA level (Plaintiff’s reading was then more than 50 times the normal range), Dr. Beaudouin referred Plaintiff to the emergency room for evaluation to rule out prostate cancer and requested that Plaintiff be evaluated by a urologist. Id. ¶¶ 54–55. On August 30, 2019, Plaintiff was taken to the Brooklyn Hospital Center, where he underwent a urinalysis but did not see a urologist or have a prostate biopsy performed; he was discharged with instructions to follow up with a urologist. Id. ¶ 56.

Free access — add to your briefcase to read the full text and ask questions with AI

Martinez v. United States Of America, (S.D.N.Y. 2021).

Martinez v. United States Of America (Martinez v. United States Of America) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Roth v. Jennings
489 F.3d 499 (Second Circuit, 2007)
Donato Dalrymple v. United States
460 F.3d 1318 (Eleventh Circuit, 2006)
Turner Ex Rel. Turner v. United States
514 F.3d 1194 (Eleventh Circuit, 2008)
City of Revere v. Massachusetts General Hospital
463 U.S. 239 (Supreme Court, 1983)
Federal Deposit Insurance v. Meyer
510 U.S. 471 (Supreme Court, 1994)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Keene Corporation v. United States
700 F.2d 836 (Second Circuit, 1983)
Barbera v. Smith
836 F.2d 96 (Second Circuit, 1987)
Natalia Makarova v. United States
201 F.3d 110 (Second Circuit, 2000)
Gibbons v. Malone
703 F.3d 595 (Second Circuit, 2013)
Johnson v. Priceline.com, Inc.
711 F.3d 271 (Second Circuit, 2013)